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1. Introduction  
Soy products have been consumed in Asian countries such as China and Japan for many 
centuries. Epidemiological studies have shown a lower incidence of several chronic diseases 
in Asia when compared to Western countries, including cardiovascular diseases and certain 
types of cancer (Wu et al., 1998; Messina, 1995). These studies have suggested that 
consumption of a traditional Asian diet high in soy may play a pivotal role in preventing 
chronic diseases.  
In 1999, the Food and Drug Administration (FDA) in USA approved a health claim based on 
the role of soybean protein in reducing the risk of coronary disease. This claim establishes 
that soybean protein included in a diet low in saturated fat and cholesterol may reduce the 
risk of coronary disease (FDA, 1999; Henkel, 2000). 
Soybeans (Glycine max) are a species of legume that yields a valuable amount of oil that has 
a healthy fatty acid profile and high-quality protein that is replete in all the essential amino 
acids required for sustaining human nourishment (Young, 1991). Soybeans have 
antihypertensive, anticholesterol, and antioxidant activities, and appear to prevent several 
types of cancer (Wu et al., 1998; Messina, 1995). However, other studies suggest that soy is 
linked to health problems. Thus, soy products are best consumed in moderation to obtain 
the benefits they offer without any of the potential negative consequences. 
1.1 Composition 
Soybean products have been designated as one of world's healthiest foods due to being an 
excellent source of high quality protein as well as providing various health benefits. 
Soybean contains vegetable protein, oligosaccharides, dietary fiber, phytochemicals 
(especially isoflavones), and minerals (Anderson et al., 1999; Messina, 1999; Liu, 1999) (table 
I, Fig 1). The association of high-quality protein and phytochemicals, especially isoflavones 
(genistein and daidzein), is unique among plant-based proteins because isoflavones are not 
widely distributed in plants other than legumes (Velasquez & Bhathena, 2007).  
In addition, large amounts of secondary metabolites are also present in both seeds and 
leaves of soybean: for example, it has been reported that soybean leaves normally 
accumulate high levels of several secondary metabolites, including kaempferol and 
quercetin (Buttery & Buzzell, 1975). The beans also contain significant amounts of phytic 
acid (Garcia et al., 1997). 
Soybean products have low levels of saturated fat (Friedman & Brandon, 2001). The lipid 
content of soybean is approximately 60% polyunsaturated, 24% monounsaturated (MFA) 
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and 15% saturated (SFA). Soybean fat stands out for its high content of the polyunsaturated 
fatty acids, linoleic (C18: 2) and linolenic (C18: 3) acids, both of which are essential fatty 
acids (Anderson et al., 1999; Garcia et al., 1997). Soybean offers one of the few non-fish 
sources rich in omega-3 fatty acids, essential for various body functions. Available data 
suggest that soybean could be a good source to increase the linolenic acid intake in people 
with a poor -3 fatty acids diet. 
The protein content of soybean is 32% to 42% (depending on the variety and growth 
conditions) of which approximately 80% is composed of 2 storage globulins, 7S globulin (β-
conglycinin) and 11S globulin (glycinin), having various functional and physicochemical 
properties (Garcia et al., 1997; Kwon et al., 2002; Kwon et al., 2003). Soybean products are 
considered a good substitute for animal protein, and their nutritional value is almost 
equivalent to that of animal protein because soy proteins contain most of the essential amino 
acids for human nutrition.  
Soybeans cannot be eaten raw; the heat-labile antinutrients (e.g. trypsin and chymotrypsin 
inhibitors) must undergo effective thermal inactivation to improve soy’s digestibility and its 
sulfur amino availability in humans (Damodaran, 1996). Traditional methods of preparing 
soybeans for consumption include germination, cooking, roasting, and fermenting. Soy can 
be used as alternative to a variety of dairy and meat products. People who are intolerant of 
lactose can eat imitation dairy products. Along with providing alternative options of certain 
foods, soy protein and isoflavones are thought to have many health benefits. 
 
Composition Soybean seeds 
Complex carbohydrates (g) 21 
Simple carbohydrates (g) 9 
Water (g) 8.5 
Vitamin C (mg) 6 
Niacin (mg) 1,6 
Choline (mg) 115.9 
Vitamin E (mg) 0.85 
Protein (g) 36 
Total fat (g) 19 
Saturated fat (g) 2.8 
Monounsaturated fat (g) 4.4 
Polyunsaturated fat (g) 11.2 
Phytosterols (mg) 161 
Fiber, total dietary (g) 9.3 
Calcium (mg) 276 
Magnesium (mg) 280 
Potassium (mg) 1.797 
Iron (mg) 16 
Zinc (mg) 4.8 
Table 1. Nutrition profile of soybeans expressed per 100g Dry Matter. Data extracted from 
the USDA National Nutrient Database for Standard reference (USDA, 2009). 
Isoflavones and soy proteins are the two major groups of components that have received the 
most attention (Xiao, 2008; Friedman & Brandon, 2001; Omoni, 2005). Isoflavones belong to a 
broad group of plant derived compounds that have structural and functional similarities to 
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estrogens, and this has led to the term phytoestrogens (Setchell, 1998). The analysis, 
bioavailability, and health effects of isoflavones have been extensively studied and frequently 
reviewed (Cassidy et al., 2006; Larkin et al., 2008). Consumption of isoflavones has been 
suggested to have multiple beneficial effects on certain types of cancer (Adlercreutz, 2002; 
Gullett et al., 2010; Sarkar, 2003), bone functions (Zhang et al., 2008), and prevention of obesity 
(Orgaard, 2008; Velasquez & Bhathena, 2007). Soy protein has also been shown to have several 
beneficial effects, including cardiovascular and others related to obesity and renal functions 
(Velasquez & Bhathena, 2007; Anderson et al., 1999; Anderson, 2008).  
Several studies suggest that soybean products seem to have a positive effect on lipids 
(Anderson et al., 1995), diabetes (Chandalia et al., 2000), diarrhoea and constipation and as a 
therapy of irritable bowel syndrome (Bosaeus, 2004); they have also anti- inflammatory and 
anti-carcinogenic effects on digestive system (Scheppach et al., 2004). Thus, we will focus at 
describing some of the beneficial effects of soybean products and discuss some 
controversies. 
 
 
Carbohydrate=30.2%    Protein=36.5% 
 50% soluble     Contains all 8 essential amino acids 
 50% insoluble 
 
 
 
 Ash=4.9%  Fiber=9%  Fats=19.9% 
g / 100g 
SFA  2.8 
MFA  4.4 
PUFA  11.2 
Cholesterol  0 
Fig. 1. The percentage nutrient composition of whole soy. Soybean seeds consist of 
approximately 36% protein, 30% carbohydrate, 20% fat, 9% crude fiber, and 5% ash (Garcia 
et al., 1997). Data extracted from the USDA National Nutrient Database for Standard 
reference (USDA, 2009). 
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2. Beneficial effects of soy products  
2.1 Lowering cholesterol/reducing heart disease 
The atheroprotective effects of soy-based diets have been attributed to its effect on reducing 
serum cholesterol levels in animal and human nutrition studies (Anthony et al., 1997; 
Jenkins et al., 2002; Reynolds et al., 2006). Although, other studies reveal that soybeans have 
also atheroprotective effects independent of the lipid-lowering activity (Ni et al., 1998; 
Adams et al., 2002; Nagarajan et al., 2008).  
Eating soy protein in particular, has been shown to reduce levels of both cholesterol and 
blood lipids (Anderson et al., 1995). Extensive clinical and experimental evidence links 
hypertension and atherosclerotic vascular disease with the accumulation of oxidized LDL 
and the enhanced generation of reactive oxygen species within the vascular walls (Stocker & 
Keaney, 2004). We have previously described that soybean oil decreased plasma levels of 
cholesterol (total and non-HDL) and triglycerides in an aged animal model of type 2 
diabetes with hyperlipidemia (Sena et al., 2008a). Thus, the lipid-lowering properties of soy 
products are very important in this context. Moreover, recent studies in the atherosclerosis-
susceptible apolipoprotein E knockout mouse models showed that atherosclerotic lesions 
are reduced when fed a soy-containing diet despite unchanged serum lipid levels (Ni et al., 
1998; Adams et al., 2002; Nagarajan et al., 2008). These studies suggest that dietary soy may 
inhibit atherosclerotic lesion development by mechanism(s) other than lowering serum lipid 
levels. Furthermore, other studies have demonstrated that mice fed the β-conglycinin-
containing diet, had a pronounced inhibitory effect on the development of atherosclerosis 
compared to mice fed casein–lactalbumin-based diets (Adams et al., 2002; Adams et al., 
2004). These findings suggest an atheroprotective role for the protein components of soy diet 
or peptides generated from soy protein such as β-conglycinin and glycinin.  
Although not completely elucidated there are several components in the soy that have 
atheroprotective properties. Several studies suggest that soybean dietary fiber also plays a 
role in the reduction of cholesterol levels in some hyperlipidemic individuals and has a 
major protective effect on cardiovascular disease (Anderson et al., 1995; Anderson et al., 
1999; Reynolds et al., 2006).  
The protective effect of soy protein has been investigated in many clinical trials. Several 
meta-analyses show that the intake of soy protein could lead to a significant mean reduction 
in serum LDL (Anderson et al., 1995; Reynolds et al., 2006; Weggemans & Trautwein, 2003; 
Zhan & Ho, 2005; Balk et al., 2005). A significant reduction in triglyceride was also found in 
two of the studies (Anderson et al., 1995; Balk et al., 2005). Overall, these meta-analyses of 
individual clinical trials concluded a beneficial effect on serum cholesterol level through the 
consumption of 25–50 g of soy protein daily (Anderson et al., 1995; Reynolds et al., 2006; 
Weggemans & Trautwein, 2003; Zhan & Ho, 2005; Balk et al., 2005). 
Replacing saturated fat by polyunsaturated fat as the main source of dietary fat intake is 
effective in reducing serum LDL and preventing atherosclerosis (Rudel et al., 1995; Mensink 
et al., 1992). A meta-analysis of 60 clinical trials further concluded that polyunsaturated fat 
from soy oil could increase the concentration of HDL-cholesterol, which is important for 
cardiovascular health (Mensink et al., 2003). 
One randomized, controlled clinical trial found significant reductions in both systolic and 
diastolic blood pressure for those consuming 40 g of soy protein supplement daily after 12 
weeks, when compared with control subjects who received complex carbohydrate (He et al., 
2005). The study provided valuable evidence of soy protein as a substitute for carbohydrate, 
but long-term studies are required to confirm its beneficial effects. 
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Consumption of isoflavones has also been suggested to have multiple beneficial effects on 
heart disease (Clair & Anthony, 2005; Clarkson, 2002). Soya products contain significant 
amounts of the isoflavones genistein and daidzein either in an unconjugated aglycone form 
or in different glycoside conjugates (Setchell, 1998; Williamson & Manach, 2005). Although 
there is controversy concerning the benefits of soy isoflavones (Sacks et al., 2006a), it is clear 
that isoflavones can modulate vascular reactivity and have important anti-inflammatory 
roles via the activation of estrogen receptors and/or intracellular kinase signalling cascades 
(Li et al., 2006). The gender specific bioavailability data of isoflavones and its metabolites is 
very important to formulate food composition/ matrix characteristic of soy-based functional 
foods. A randomised crossover human trial has examined the effect of age, gender, and 
influence of the food matrix on the bioavailability of different soy foods (Cassidy et al., 
2006), but more convincing human studies are required to make a definite health claim.  
A clinical trial evaluating the benefits of soy isoflavones reported increased brachial artery 
flow-mediated dilation (Squadrito et al., 2003). Clarkson (2002) reported plasma 
concentrations of genistein and daidzein that range between 50 and 800 ng/mL in adults 
consuming soy-rich foods, similar to levels found in the Japanese population. 
Several human studies during last years are not in agreement with the beneficial effect of 
soy isoflavones (Sacks et al., 2006b), rather the evidence favours soy protein. However, the 
American Heart Association Nutrition Committee has not ruled out the possibility that 
another component could be the active factor (Sacks et al., 2006b). 
Discrepancies among clinical studies examining cardiovascular benefits of isoflavones may 
be influenced not only by the ability of intestinal bacteria to metabolize daidzein to equol 
but also by an individual’s metabolic status. Studies in rodent models (Mahn et al., 2005; 
Knock et al., 2006; Si & Liu, 2008), have shown that dietary isoflavones supplementation 
increases antioxidant and eNOS gene expression. 
Current evidence from several small studies suggests that omega-3 and soy isoflavone 
supplementation provides an effective means of reducing arterial stiffness (Pase et al., 2011). 
There is also a growing body of evidence suggesting that soy food consumption is 
associated with a significant reduction in ischemic stroke risk (Liang et al., 2007; Liang et al., 
2009). 
2.2 Reducing cancers 
Epidemiological studies suggest that populations consuming high levels of soybean 
products (Asian countries) have both lower incidences of cancer and lower mortality rates 
for the major tumor types commonly found in Western countries. 
The soluble fiber in soy products is claimed to help protect the body from many digestive 
related cancers (Scheppach et al., 2004). In vitro studies, animal experiments and 
epidemiological observations have shown that consumption of soybean products reduce 
cancer risk and it is associated with overall low mortality rates due to prostate (Jacobsen et 
al., 1998; Lee et al., 2003; Hwang et al., 2009), breast (Wu et al., 1998; Yamamoto et al., 2003) 
and endometrial cancers (Goodman et al., 1997). In a study of 59 countries, soy products 
were found to be significantly protective with an effect size per kilocalorie at least four times 
greater than that of any dietary factor (Lee et al., 2003).  
Soybean contains a variety of phytochemicals with demonstrated anticancer activity (Park et 
al., 2005). The most widely studied bioactive substances are the isoflavones and the 
Bowman–Birk protease inhibitor (BBI). The chemopreventive properties of soybean 
isoflavones have been attributed to different biological activities, mainly to their long-term 
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estrogenic effects and their antioxidant activity (McCue & Shetty, 2004). BBI works by 
inhibiting proteases involved in initiation and promotion of carcinogenesis (Kennedy et al., 
1998). Its capacity for preventing or suppressing carcinogenic processes has been 
demonstrated in different cell lines as well as in a wide variety of in vitro and in vivo animal 
model systems (Losso, 2008). It is currently being evaluated in large-scale human trials as an 
anti-carcinogenic agent in its less pure form BBI concentrate (Losso, 2008).  
Other soy proteins, including lectins and the more recently discovered peptide lunasin, may 
contribute to the role of soy in the prevention and/or treatment of cancer (Hernández-
Ledesma et al., 2009). The processing of soy protein into peptides in the gastro-intestinal 
tract greatly increases their healthful effects by exposing active groups within the amino 
acid chain. Lunasin, one of the most promising of these peptides, has been shown in recent 
studies to be an effective anti-cancer agent. Found in a variety of readily available foods, 
lunasin is an accessible component to healthy living (Hernández-Ledesma et al., 2009).  
Consumption of soy may also reduce the risk of colon cancer, possibly due to the presence 
of sphingolipids (Symolon et al., 2004).  
Dietary factors present in soybean foods have also been implicated in the etiology of breast 
cancer and soy isoflavones has been a candidate for dietary intervention. The majority of the 
studies describe a benefit of soy products; a few studies do not show benefits. In the breast, 
soy intake during childhood and adolescence might provide lifelong protection against 
breast cancer and sensitize for the protective effects of adult soy intake (Korde et al., 2009; 
Lee et al., 2009; Wu et al 2002).  
In 2006 the American Cancer Society (ACS) issued some key information on soy-derived 
foods indicating they are an excellent food source and a good alternative to meat (Doyle et 
al., 2006). The ACS recommends that breast cancer survivors should consume only 
moderate amounts of soy foods as part of a healthy plant-based diet. Although two recent 
human studies in breast cancer survivors did not indicate adverse effects (Guha et al., 2009; 
Shu et al., 2009) and suggest a reduction in the risk of recurrence in Asian women 
consuming soy regularly, more studies are needed to determine whether Western soy 
products or isoflavone supplements are safe for women diagnosed with breast cancer. 
Furthermore, the ACS advises these same individuals against the deliberate ingestion of 
large amounts of soy products in the diet and discourages the consumption of concentrated 
sources of soy like those found in pills, powders, or supplements containing isolated or 
concentrated isoflavones.  
Inconclusive evidence from epidemiological studies, a small number of prospective studies 
and errors in the estimation of soy and isoflavone intake, in addition to the existence of 
hidden sources of soy makes it difficult to address this research accurately. There is a need 
for more prospective studies—with extensive exposure measurement. To interpret the data, 
isoflavone dose, forms and sources of isoflavone, timing of isoflavone exposure, and the 
equol producer status, estrogen-receptor status, and hormonal profile of individuals, need 
to be considered since they potentially modulate the association between soy intake and 
cancer risk. Other dietary, environmental, and genetic factors may also modify the 
association. Future studies need to address these questions by including samples large 
enough to detect the factors that are capable of modifying the associations between soy and 
cancer risk. 
2.3 Reducing menopausal symptoms 
Isoflavones have emerged as alternatives to classical hormonal therapy in menopause, yet 
there are still conflicting reports on their vascular health benefits. Recent evidence in 
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postmenopausal women supplemented with genistein for six months reveals a significant 
improvement in glycemic control and endothelial function compared to a placebo group 
(Villa et al., 2009). These investigators emphasized that an individual’s pre-existing 
metabolic status may affect responses to isoflavone therapy.  
Studies evaluating the effectiveness of soy foods in ameliorating vasomotor and vaginal 
symptoms have been conducted and have utilized a variety of soy foods containing 
different amounts of isoflavones. Among these studies the results are diverse, 10 studies 
published in the last 20 years, some have had negative results and one reported worsening 
of symptoms in the group consuming soy food. Some studies have assessed only vaginal 
cytology, one study has assessed vasomotor symptoms and reported a reduction in 
symptoms. Two studies evaluated both outcomes, with opposite findings. In conclusion, 
considering the conflicting results provided by a small number of studies, the efficacy of soy 
foods in improving menopausal symptoms remains unclear [for extensive review see Levis 
& Griebeler, 2010]. 
Noteworthy, the beneficial effects of soy are more convincing if soy has been consumed 
throughout life rather than if the intake starts at menopause (Mardon et al., 2008; Piekarz et 
al., 2007). 
2.4 Improving bone health 
Studies in Asia found a link between greater intake of isoflavones and stronger bones. 
Japanese women have a lower rate of hip fractures than American women, but that might be 
because of genetics or other factors. Clinical observations have suggested a relationship 
between osteoarthritis and a changed estrogen metabolism in menopausal women. 
Moreover phytoestrogens have been shown to ameliorate various menopausal symptoms 
(Claassen et al., 2008). The effect of phytoestrogens, including genistein, has been studied on 
articular cartilage matrix metabolism and inflammation. Nevertheless, the data for genistein 
and osteoarthritis are limited and not consistent to support a beneficial effect of genistein on 
articular cartilage. Genistein does not affect cartilage metabolism (Claassen et al., 2008; 
Hooshmand et al., 2007) but could have an anti-inflammatory effect by suppressing COX-2 
but not nitric oxide production (Hooshmand et al., 2007). In addition, the consumption of an 
extract of soy phytoestrogen in animal failed to modify cartilage metabolism in 
ovariectomised monkey (Ham et al., 2004). Additional experiments are needed to clarify the 
potential benefit of genistein in articular cartilage metabolism. 
More recently, basic scientific research studies and a systematic review and meta-analysis of 
the available high-quality randomized clinical trials indicate that 300 mg of avocado and 
soybean unsaponifiables per day (with or without glucosamine and chondroitin sulfate) 
appears to be beneficial for patients with hip or knee osteoarthritis (Dinubile, 2010). 
2.5 Improving diabetic conditions 
Animal and human studies have been conducted to investigate antidiabetic effects of 
soybeans and their actions (Trujillo et al., 2005; Chandalia et al., 2000; Pipe et al., 2009; 
Azadbakht et al., 2008). Previous observations have shown that soya-containing diets were 
associated with an improvement in insulin resistance and glycemic control (Kwon et al., 
2010). It has also been suggested that the protein and fiber found in soy help to regulate 
blood glucose levels and kidney filtration, thereby, helping to control diabetic complications 
along with kidney disease. Hence, soybeans may help prevent type 2 diabetes and delay its 
progression.  
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Soybean diet may be a good option in type 2 diabetes individuals due to its effect on 
hypertension, hypercholesterolemia, atherosclerosis and obesity, which are frequently 
associated with diabetic disease (Holt et al., 1996). 
In addition, substituting animal protein for soybean or other vegetable protein may also 
decrease renal hyperfiltration, proteinuria, and renal acid load and therefore reduces the 
risk of renal disease in type 2 diabetes (Jenkins et al., 2003).  
It is generally accepted that a high fiber diet, particularly soluble fiber, is useful to control 
plasma glucose concentration in diabetics. Soybean fiber may be useful because of its 
insulin-moderated effect. In short- and long-term experiments it has been reported an 
improvement in blood glucose attributed to fiber intake from soybeans (Messina, 1999; 
Chandalia et al., 2000). The mechanisms to improve glycemic control during dietary fiber 
intake seem to be due to the effects of slowing carbohydrate absorption, so that dietary fiber 
reduces or delays the absorption of carbohydrates. Soybean dietary fiber also increases 
faecal excretion of bile acid and therefore may cause a low absorption of fat (Chandalia et 
al., 2000; Jenkins et al., 2003) and reduces the caloric density in some foods (Liu, 1999).  
Additionally, an increased consumption of n-3 PUFA coupled with a reduced intake of 
saturated fat has been suggested to reduce the risk of progression from impaired glucose 
tolerance to type 2 diabetes in overweight subjects (Nettleton & Katz, 2005). We have 
previously shown that after 8 weeks of treatment with soybean oil young Goto-Kakizaki 
(GK) rats had a significant decrease in glycated haemoglobin accompanied by a significant 
decrement in fasting blood glucose levels (Sena et al., 2008b). The improved diabetic profile 
is probably due to the soybean oil antioxidant composition, namely -tocopherol and 
coenzyme Q. Moreover, it has recently been described that dietary phytoestrogens activate 
AMP-activated protein kinase with improvement in lipid and glucose metabolism 
(Cederroth et al., 2008), thus other constituents may be involved. 
Isoflavones are structurally and functionally similar to estradiol (Knight & Eden, 1996). 
Thus, soy isoflavones may improve glucose homeostasis through their estrogenic action. 
The estrogen receptor  is emerging as a key molecule involved in glucose and lipid 
metabolism. Isoflavones may have antidiabetic actions through estrogen receptors.  
Soybean isoflavones and protein consumption alleviate some of the symptoms associated 
with type 2 diabetes (Davis et al., 2005; Mezei et al., 2003). However, human clinical trials 
are contradictory (Sites et al., 2007; González et al., 2007). Some studies report that 
consumption of isolated isoflavones did not affect insulin sensitivity as assessed by an oral 
2-hour glucose tolerance test in a crossover study of postmenopausal women, even though 
serum ghrelin levels were decreased by the isoflavonoid treatment, indicating some changes 
in appetite (Nikander et al., 2004). In addition, insulin secretion, visceral fat, total body fat, 
and lean body mass did not change among postmenopausal women who consumed soy 
protein for 3 months compared with those that consumed casein protein (Sites et al., 2007). 
A 6-month randomized controlled trial did not support the hypothesis that soy protein with 
or without isoflavone supplementation had favorable effects on glycemic control and insulin 
sensitivity among postmenopausal Chinese women (Liu et al., 2010). A recent meta-analysis 
of 24 trials and more than 1,500 subjects reported no significant overall effect of soy intake 
on fasting glucose and insulin concentrations. There were not enough trials to generate 
sufficient evidence for other glycemic variables, such as HbA1c and 2-h postchallenge 
glucose and insulin concentrations (Liu et al., 2011). However, some studies have shown 
positive effects. For instance, postmenopausal women taking dietary supplementation with 
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phytoestrogens had significantly improved glycemic control, insulin resistance and serum 
lipoproteins (Jayagopal et al., 2002; González et al., 2007). In a recent meta-analysis of 
randomized clinical trials, there was a favorable change in fasting glucose concentrations 
observed in studies that used whole soy foods or a soy diet in the subgroup analysis (Liu et 
al., 2011). 
Recent experiments have shown that isoflavones in soybeans enhance insulin secretion and 
insulin sensitivity in experimental animal models of diabetes (Lu et al., 2008; Cederroth et 
al., 2008; Noriega-López et al., 2007), and that soy protein attenuates insulin resistance in 
male Sprague-Dawley rats (Ronis et al., 2009). Phytoestrogens seem to modulate energy 
expenditure, adiposity and glucose tolerance in rodents (for review see Cederroth & Nef, 
2009). However, the effect of isoflavones and soy protein remains unclear, although several 
studies have revealed mechanisms by which soy isoflavones may impact glucose 
metabolism (Ronis et al., 2009). 
Soy foods are beneficial for decreasing the risk of onset and progression of insulin resistance 
and type 2 diabetes and the effectiveness is enhanced by fermentation. Phytoestrogens and 
proteins in soybeans seem to have beneficial actions, and additional micronutrients such as 
saponins, phytosterols, trypsin inhibitors, as well as the amino acid and protein composition 
may have additive or synergistic effects. Fermentation of soybeans leads to structural 
changes in proteins and phytoestrogen, which may contribute to more beneficial effects on 
glucose metabolism. Investigating soybeans and fermented soy products have not used 
standardized formulations, doses, routes of exposure, durations of exposure, and 
subsequent analyses to evaluate antidiabetic effects and mechanisms of action.  
Studies performed in diabetic patients with soybean diets show several potential 
advantages, but at the moment more work is required to define the exact role of soybean in 
the control of diabetes mellitus.  
3. Opposing viewpoints on the health benefits of soybeans  
Currently, there are opposing viewpoints on the health benefits of soy products. Some 
studies suggest that soy is linked to health problems including: malnutrition, digestive 
distress, thyroid dysfunction, cognitive decline, reproductive disorders, infertility, birth 
defect, immune system breakdown, and cancer (Leopald, 1976; Setchell et al., 1987; Doerge, 
2002; Helferich et al., 2008; Xiao, 2008; Patisaul & Jefferson, 2010; Cederroth et al., 2010, Bar-
El & Reifen, 2010). 
Soybeans contain haemagglutinin, a clot-promoting substance. Haemagglutinin and trypsin 
inhibitors can act as growth inhibitors. Weanling rats fed soy containing these antinutrients 
fail to grow normally. However, these growth-depressant compounds are deactivated 
during the process of fermentation (Borchers, 1962). 
A very large percentage of soy is genetically modified (more than 99 %) and it also has one 
of the highest percentages of contamination by pesticides. Recent studies on safety 
assessment of genetically modified soybeans showed rather contradictory results. Two 
research groups have been especially active in relation to those investigations. One of them, 
headed by Dr. Delaney from Pioneer Hi-Bred International, Inc. (Johnston, IA, USA), has 
reported data showing that various genetically modified soybeans were safe. In contrast, the 
group headed by Dr. Malatesta from the University of Verona (Verona, Italy) has shown 
notable concerns (Delaney et al., 2008; Malatesta et al., 2008a; Malatesta et al., 2008b). 
Certain pesticides are known to increase the incidence of several types of cancers 
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(Weichenthal et al., 2010). Thus, contamination of soybeans with pesticides may explain the 
increase risk of certain types of cancer. 
The soybean has one of the highest phytate levels of any grain or legume that has been 
studied (El Tinay, 1989), and the phytates in soy are highly resistant to normal phytate-
reducing techniques such as long, slow cooking (Ologhobo et al., 1984). Only a long period 
of fermentation will significantly reduce the phytate content of soybeans. Phytates can block 
the uptake of essential minerals - calcium, magnesium, copper, iron and especially zinc - in 
the intestinal tract. Diets high in phytates contribute to widespread mineral deficiencies in 
third world countries (Moser et al., 1988; Harland et al., 1988).  
When soy products like tofu are consumed with meat, the mineral-blocking effects of the 
phytates are reduced (Sandström et al., 1989). The Japanese traditionally eat a small amount 
of tofu or miso as part of a mineral-rich fish broth, followed by a serving of meat or fish. 
However, vegetarians who consume tofu and bean curd as a substitute for meat and dairy 
products risk severe mineral deficiencies.  
Zinc is needed for the optimal development and functioning of the brain and nervous 
system (Takeda & Tamano, 2009). It plays a role in protein synthesis and collagen formation; 
it is involved in the blood-sugar control mechanism and thus protects against diabetes 
(Jansen et al., 2009); it is also needed for a healthy reproductive system (Eickhoff et al., 2004). 
Zinc is a key component in numerous vital enzymes and plays a role in the immune system. 
Phytates found in soy products interfere with zinc absorption more completely than with 
other minerals (Greger, 1999).  
Soy protein isolate (SPI) is the key ingredient in most soy foods that imitate meat and dairy 
products, including baby formulas and some brands of soy milk. Much of the trypsin 
inhibitor content can be removed through high-temperature processing, but not all. Trypsin 
inhibitor content of soy protein isolate can vary as much as fivefold (Rackis et al., 1986). But 
high-temperature processing has the unfortunate side-effect of so denaturing the other 
proteins in soy that they are rendered largely ineffective (Wallace et al., 1971a; Wallace et al., 
1971b). Thus, animal models feed with soybean diets need aminoacid supplements for 
normal growth.  
In feeding experiments, the use of SPI increased requirements for vitamins E, K, D and B12 
and created deficiency symptoms of calcium, magnesium, manganese, molybdenum, 
copper, iron and zinc (Rackis, 1974). Phytic acid remaining in these soy products greatly 
inhibits zinc and iron absorption; test animals fed SPI develop enlarged organs, particularly 
the pancreas and thyroid gland, and increased deposition of fatty acids in the liver (Rackis, 
1974). 
Soy protein isolate and textured vegetable protein are used extensively in school lunch 
programs, commercial baked goods, diet beverages and fast food products. "Nutritional 
Quality of Soy Bean Protein Isolates: Studies in Children of Preschool Age", studied a group 
of Central American children suffering from malnutrition. Researchers did not use soy 
products to help the children recover from malnutrition. Instead, a supplement with soy-
sugar mixture and nutrients (largely absent in soy products - notably, vitamins A, D and 
B12, iron, iodine and zinc) was used.  
3.1 Isoflavones have harmful side effects 
Phytoestrogens tend to have weaker effects than most estrogens, are not stored in the body, 
and can be easily broken down and eliminated. They are considered to be endocrine 
disrupting compounds, and have some beneficial effects on health, including reducing the 
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risk of breast cancer and improving metabolic parameters. However, the supporting 
evidence that consumption of phytoestrogens is beneficial is indirect and inconsistent. 
Lifetime exposure to estrogenic substances, especially during critical periods of 
development, has been associated with formation of malignancies and several anomalies of 
the reproductive systems (Cederroth et al., 2010). Isoflavones can prevent ovulation and 
actually stimulate cancer cell growth (Bar-El & Reifen, 2010). 
Soy products in western countries are quite different from those consumed in the traditional 
Asian diet. Most Asian soy products use whole soybeans with or without fermentation. Soy 
products or second generation soy foods in the US are mostly based on soy protein at 
different levels of purification or extraction such as texturized vegetable protein (45% 
protein), soy protein concentrate (70% protein), or isolates (90% protein), each with a 
different profile of nutrient and non-nutrient compounds, including isoflavones and 
saponins (Setchell & Cole, 2003; Fang et al., 2004). It is likely that processing of soy foods 
modulates the profile of isoflavones and modifies their bioaccesibility and bioavailability, 
but how these differences affect cancer risk and risk of recurrence need to be investigated. 
3.2 Soy milk and infants 
It has been previously suggested that the highly concentrated phytoestrogens in soy formula 
might weaken the immune systems of infants. The authors have suggested potential 
immune, reproductive and endocrine effects in infants or adults as a result of high 
isoflavone consumption in the soy formulas (Yellayi et al., 2002). The formulas have more of 
these compounds than soy foods do. There's no evidence that soy formula is unsafe, or that 
infants drinking it have been harmed (Yellayi et al., 2002). However, breast milk is still the 
first choice, followed by milk-based formulas. Moreover, only infants allergic to milk should 
drink soy formula (Setchell et al., 1997).  
3.3 Thyroid disease 
Soy also contains goitrogens - substances that depress thyroid function. Diffuse goiter and 
hypothyroidism appeared in some of the subjects consuming soybeans and many 
complained of constipation, fatigue and lethargy, even though their intake of iodine was 
adequate (Ishizuki et al., 1991). In 1997, researchers from the FDA's National Center for 
Toxicological Research reported that the goitrogenic components of soy were the isoflavones 
(Divi et al., 1997). It has been previously suggested that soy protein supplements can 
interfere with the absorption of thyroid medications (Drane et al., 1980). One study showed 
that soy foods may actually interfere with normal thyroid function, perhaps leading to 
goiter (Kimura et al., 1976).  
There's no risk of goiter in healthy people consuming soy that are not deficient in iodine. 
Strict vegetarians, who eat no iodine-rich fish or dairy products, might be at risk—and 
eating higher amounts of soy might increase the risk. A healthy balanced diet with the 
appropriate amounts of soy and iodine intake is essential (Fitzpatrick, 2000).  
3.4 Kidney stones 
People with higher risk of development of calcium-oxalate kidney stones should limit their 
intake of soy. Many soy foods are rich in oxalates and thus may promote the formation of 
such stones in those at risk (Al-Wahsh et al., 2005).  On the other hand, soybean is associated 
with health benefits for patients with gallstones. The mechanism of beneficial effect of 
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soybean on gallstones is not well known but it may be related to the blood cholesterol 
lowering effects of soybean protein containing isoflavones (Holt et al., 1996). 
4. Conclusion 
Soy foods have been consumed for centuries in Asian countries. Many potential benefits have 
been linked to intake of soy products according to epidemiological investigations. For instance, 
consumption of soy foods may contribute to lower incidences of coronary heart diseases, 
atherosclerosis, type 2 diabetes, and decreased risk of certain types of cancer such as breast 
and prostate cancers as well as better bone health and relief of menopausal symptoms. 
The American Dietetic Association’s position on vegetarian diets indicates that certain eating 
patterns may reduce risk of chronic disease, and soy products and phytochemicals are 
included in the list of influential dietary factors (Nitzke & Freeland-Graves, 2007; Craig & 
Mangels, 2009). Moreover they also acknowledged that even foods associated with a healthful 
diet, such as soybeans, should not be viewed oversimplistically as being ideal, or good or bad, 
but instead their value should be ascertained within the context of the total diet.  
Perhaps an effort to investigate whole soy, knowing that more than one component of this 
food is likely implicated if appreciable health benefits can be attributed to its consumption 
outside of Asian populations.  
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